Go Pro

Calian Group Ltd. (TSE:CGY) Given Consensus Recommendation of "Buy" by Brokerages

Calian Group logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Analysts are unanimously bullish on Calian Group, with all nine covering brokerages issuing “Buy” ratings and an average 12-month price target of C$92.06, above the C$80.42 share price.
  • Several firms recently raised their targets, with ATB Cormark, Stifel Nicolaus and Ventum setting objectives between C$98.50 and C$100.00.
  • Calian reported quarterly revenue of C$228.70 million and EPS of C$1.30, while maintaining a quarterly dividend of C$0.28 per share, equivalent to a 1.4% yield.
  • MarketBeat previews the top five stocks to own by September 1st.

Shares of Calian Group Ltd. (TSE:CGY - Get Free Report) have been given an average recommendation of "Buy" by the nine analysts that are covering the stock, Marketbeat reports. Nine analysts have rated the stock with a buy recommendation. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is C$92.06.

CGY has been the subject of several recent research reports. ATB Cormark Capital Markets boosted their price target on Calian Group from C$92.50 to C$98.50 and gave the company an "outperform" rating in a research note on Tuesday, May 19th. Stifel Nicolaus set a C$100.00 price objective on Calian Group and gave the stock a "buy" rating in a research note on Wednesday, May 20th. Canadian Imperial Bank of Commerce lifted their price objective on Calian Group from C$76.00 to C$90.00 in a report on Friday, May 15th. Royal Bank Of Canada upped their target price on Calian Group from C$78.00 to C$90.00 and gave the company an "outperform" rating in a research report on Friday, May 15th. Finally, Ventum increased their target price on Calian Group from C$94.00 to C$100.00 and gave the stock a "buy" rating in a report on Monday, June 15th.

Get Our Latest Stock Analysis on CGY

Calian Group Trading Up 0.0%

CGY stock opened at C$80.42 on Friday. The company has a debt-to-equity ratio of 63.54, a quick ratio of 1.20 and a current ratio of 1.51. The company's 50-day simple moving average is C$82.12 and its 200 day simple moving average is C$76.55. Calian Group has a 52 week low of C$44.89 and a 52 week high of C$92.34. The company has a market capitalization of C$924.11 million, a PE ratio of 28.22, a price-to-earnings-growth ratio of 2.50 and a beta of 0.96.

Calian Group (TSE:CGY - Get Free Report) last posted its quarterly earnings data on Thursday, May 14th. The company reported C$1.30 earnings per share (EPS) for the quarter. Calian Group had a net margin of 3.97% and a return on equity of 10.35%. The firm had revenue of C$228.70 million during the quarter. As a group, sell-side analysts anticipate that Calian Group will post 4.9475219 earnings per share for the current year.

Calian Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, June 10th. Investors of record on Wednesday, June 10th were given a dividend of $0.28 per share. The ex-dividend date of this dividend was Wednesday, May 27th. This represents a $1.12 annualized dividend and a yield of 1.4%. Calian Group's dividend payout ratio is currently 39.30%.

Insider Transactions at Calian Group

In other Calian Group news, insider Patrick Belanger Houston sold 6,432 shares of the stock in a transaction dated Wednesday, May 20th. The shares were sold at an average price of C$80.91, for a total transaction of C$520,413.12. Following the sale, the insider directly owned 22,266 shares in the company, valued at C$1,801,542.06. This represents a 22.41% decrease in their ownership of the stock. 0.63% of the stock is owned by insiders.

About Calian Group

(Get Free Report)

Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.

See Also

Analyst Recommendations for Calian Group (TSE:CGY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Calian Group Right Now?

Before you consider Calian Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calian Group wasn't on the list.

While Calian Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines